0
Skip to Content
BrightHeart
Careers
Request a Demo
BrightHeart
Careers
Request a Demo
Careers
Request a Demo

BrightHeart to Present Groundbreaking AI-Driven Research at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting

Jan 13
Written by Amanda French
Amanda French
Previous
Previous

How BrightHeart uses Meta’s DINOv2 to transform fetal heart screenings

Next
Next

BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations

Contact

contact@brightheart.ai

BrightHeart – chez Sofinnova Partners
7-11 Bd Haussmann, 75009 Paris

Patents

Security

Privacy Policy

Website Terms of Use

Product Regulatory Information

Get in touch
  1. Lam-Rachlin et. al., “Use of Artificial Intelligence–Based Software to Aid in the Identification of Ultrasound Findings Associated With Fetal Congenital Heart Defects,” Obstetrics & Gynecology, 2025.

  2. Rebarber et. al., “Optimizing screening for severe congenital heart defects on prenatal ultrasound using eight suspicious findings and artificial intelligence”, ISUOG abstract, 2025.

  3. B-Right Views is a Class II FDA-cleared and a Class IIa CE marked (Notified Body: 3022) medical device, please refer to product regulatory information for more details.

  4. B-Right Screen is a Class II FDA-cleared and a Class IIa CE marked (Notified Body: 3022) medical device, please refer to product regulatory information for more details.

  5. https://childrensheartlink.org/congenital-heart-disease-facts/#:~:text=Every%205%20minutes%2C%2010%20children,1.3%20million%20children%20each%20year.

  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC7317409/

  7. https://pubmed.ncbi.nlm.nih.gov/12084585/

  8. https://pubmed.ncbi.nlm.nih.gov/18657826/

  9. https://pubmed.ncbi.nlm.nih.gov/32795094/

  10. Lam-Rachlin et. al., “Enhancing Ultrasound Standard View Completion in Fetal Heart Screening with an AI Software,” ISUOG abstract, 2025.

  11. Zelop et al., “Artificial Intelligence Accurately Detects Fetal Ultrasound Findings Suspicious For Major Congenital Heart Defects,” Obstetrics & Gynecology, 2025. *Stats presented among conclusive cases.
    Note: Images shown may represent the range of products and differ from versions, or be for illustration purposes only, and may not be an exact representation of the product.
    For use only in countries with applicable health authority registrations: please contact us for more information.

© 2026 BrightHeart.
All rights reserved.

Design: Units